Cutler Group’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $62K | Sell |
17,900
-8,900
| -33% | -$30.8K | 0.02% | 342 |
|
2023
Q4 | $38K | Hold |
26,800
| – | – | ﹤0.01% | 720 |
|
2023
Q3 | $39K | Hold |
26,800
| – | – | ﹤0.01% | 753 |
|
2023
Q2 | $42K | Hold |
26,800
| – | – | 0.01% | 657 |
|
2023
Q1 | $41K | Hold |
26,800
| – | – | ﹤0.01% | 683 |
|
2022
Q4 | $45K | Hold |
26,800
| – | – | ﹤0.01% | 846 |
|
2022
Q3 | $32K | Hold |
26,800
| – | – | ﹤0.01% | 1042 |
|
2022
Q2 | $44K | Hold |
26,800
| – | – | ﹤0.01% | 918 |
|
2022
Q1 | $65K | Hold |
26,800
| – | – | ﹤0.01% | 951 |
|
2021
Q4 | $100K | Hold |
26,800
| – | – | ﹤0.01% | 935 |
|
2021
Q3 | $168K | Sell |
26,800
-4,500
| -14% | -$28.2K | 0.01% | 757 |
|
2021
Q2 | $308K | Sell |
31,300
-21,912
| -41% | -$216K | 0.01% | 574 |
|
2021
Q1 | $497K | Buy |
+53,212
| New | +$497K | 0.02% | 404 |
|
2020
Q4 | – | Sell |
-400
| Closed | -$1K | – | 2487 |
|
2020
Q3 | $1K | Buy |
+400
| New | +$1K | ﹤0.01% | 1624 |
|
2020
Q2 | – | Sell |
-300
| Closed | – | – | 2221 |
|
2020
Q1 | $0 | Buy |
300
+100
| +50% | – | ﹤0.01% | 2171 |
|
2019
Q4 | $0 | Buy |
+200
| New | – | ﹤0.01% | 2260 |
|
2019
Q1 | – | Sell |
-500
| Closed | -$1K | – | 2310 |
|
2018
Q4 | $1K | Buy |
+500
| New | +$1K | ﹤0.01% | 1544 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 2285 |
|
2018
Q2 | – | Sell |
-600
| Closed | -$2K | – | 2371 |
|
2018
Q1 | $2K | Sell |
600
-300
| -33% | -$1K | ﹤0.01% | 1675 |
|
2017
Q4 | $5K | Buy |
+900
| New | +$5K | ﹤0.01% | 1816 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 3501 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 3464 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 3464 |
|